• 1
    Chan JK, Cheung MK, Husain A et al . Patterns and progress in ovarian cancer over 14 years. Obstet Gynecol 2006; 108: 5218.
  • 2
    Tingulstad S, Skjeldestad FE, Halvorsen TB, Hagen B. Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol 2003; 101: 88591.
  • 3
    Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975; 42: 1014.
  • 4
    Chi DS, Eisenhauer EL, Lang J et al . What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 2006; 103: 55964.
  • 5
    Hama Y, Urano Y, Koyama Y et al . In vivo spectral fluorescence imaging of submillimeter peritoneal cancer implants using a lectin-targeted optical agent. Neoplasia 2006; 8: 60712.
  • 6
    Yao Z, Zhang M, Sakahara H, Saga T, Arano Y, Konishi J. Avidin targeting of intraperitoneal tumor xenografts. J Natl Cancer Inst 1998; 90: 259.
  • 7
    Hama Y, Urano Y, Koyama Y, Choyke PL, Kobayashi H. Targeted optical imaging of cancer cells using lectin-binding BODIPY-conjugated avidin. Biochem Biophys Res Commun 2006; 348: 80713.
  • 8
    Stockert RJ. The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol Rev 1995; 75: 591609.
  • 9
    Hama Y, Urano Y, Koyama Y, Choyke PL, Kobayashi H. d-Galactose receptor-targeted in vivo spectral fluorescence imaging of peritoneal metastasis using galactosamine-conjugated serum albumin-rhodamine green. J Biomed Opt 2007; XX: XXXXXX.
  • 10
    Imai S, Kiyozuka Y, Maeda H, Noda T, Hosick HL. Establishment and characterization of a human ovarian serous cystadenocarcinoma cell line that produces the tumor markers CA-125 and tissue polypeptide antigen. Oncology 1990; 47: 17784.
  • 11
    Hamilton T, Young R, Ozols R. Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches. Semin Oncol 1984; 11: 28598.
  • 12
    Bérnard J, Da Silva J, De Blois M et al . Characterization of a human ovarian adenocarcinoma line, IGR-OV1, in tissue culture and in nude mice. Cancer Res 1985; 45: 49709.
  • 13
    Hama Y, Urano Y, Koyama Y, Bernardo M, Choyke PL, Kobayashi H. A comparison of the emission efficiency of four common green fluorescence dyes after internalization into cancer cells. Bioconjug Chem 2006; 17: 142631.
  • 14
    Hytonen VP, Laitinen OH, Grapputo A et al . Characterization of poultry egg-white avidins and their potential as a tool in pretargeting cancer treatment. Biochem J 2003; 372: 21925.
  • 15
    Paganelli G, Chinol M, Maggiolo M et al . The three-step pretargeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapy. Eur J Nucl Med 1997; 24: 3501.
  • 16
    Kwon AH, Matsui Y, Ha-Kawa SK, Kamiyama Y. Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol 2001; 96: 5416.
    Direct Link:
  • 17
    DeLaney TF, Sindelar WF, Tochner Z et al . Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int J Radiat Oncol Biol Phys 1993; 25: 44557.
  • 18
    Sindelar WF, DeLaney TF, Tochner Z et al . Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study. Arch Surg 1991; 126: 31824.